9-Bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine

Catalog No. :
ACDBRE609
CAS No. :
799779-27-4
Molecular Formula :
C20H14BrN3O4
Molecular Weight :
440.25

IUPAC Name:9-bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-1,10b-dihydro-5H-benzo[e]pyrazolo[1,5-c][1,3]oxazine

9-Bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-Bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-5,10b-dihydro-1H-benzo[e]pyrazolo[1,5-c][1,3]oxazine
IUPAC Name9-bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-1,10b-dihydro-5H-benzo[e]pyrazolo[1,5-c][1,3]oxazine
MDL No.MFCD02668522
Molecular FormulaC20H14BrN3O4
Molecular Weight440.25
SMILESO=[N+](C1=CC(C2OC3=CC=C(Br)C=C3C4N2N=C(C5=CC=CO5)C4)=CC=C1)[O-]
InChI KeyBDOMFGUMIZTVRY-UHFFFAOYSA-N
Synonym9-bromo-2-(furan-2-yl)-5-(3-nitrophenyl)-5,10b-dihydro-1H-pyrazolo[1,5-c][1,3]benzoxazine;5H-Pyrazolo[1,5-c][1,3]benzoxazine, 9-bromo-2-(2-furanyl)-1,10b-dihydro-5-(3-nitrophenyl)-;8-BR-2-FURAN-2-YL-4(3-NITRO-PH)1,9B-2H-5-OXA-3,3A-DIAZA-CYCLOPENTA(A)NAPHTHALENE
CAS No.799779-27-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDBRE609 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDBRE609 route product structure diagram
    ACDBRE609799779-27-4
Inquiry

2. ACDBRE609 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDBRE609 route product structure diagram
    ACDBRE609799779-27-4
Inquiry

Comments (0)